摘要
目的:了解抗抑郁药在北京地区的应用情况及发展趋势。方法:采用世界卫生组织推荐的限定日剂量为指标的分析方法,对北京地区36家医院2003年~2005年抗抑郁药的应用进行统计、分析。结果:用药金额及用药频度均逐年升高,5-羟色胺再摄取抑制剂(SSRIs)等新型抗抑郁药应用增幅较大。结论:在北京地区,氟西汀等SSRIs已成为抗抑郁药首选,三环类应用比例减少。国内厂家应增强紧迫感和危机感,尽快研制出更多安全性高、治疗效果好、价格低廉的抗抑郁药。
OBJECTIVE: To investigate the application and the development tendency of antidepressants in Beijing area. METHODS: Using the analytical method of the Defined Daily Dose (DDD) recommended by WHO, the application of antidepressants in Beijing during 2003-2005 was analyzed statistically. RESULTS: The consumptive sum and DDDs of antidepressants increased year by year, in particular the new type of antidepressants such as SSRIs. CONCLUSION: SSRIs such as Fluoxetine have become the antidepressants of first choice, but the application of TCAs (tricyclic antidepressant) has decreased in Beijing. The domestic pharmaceutical factories should have a sense of urgency and crisis and prepare antidepressants with high safety, good efficacy and low cost as soon as possible.
出处
《中国药房》
CAS
CSCD
北大核心
2006年第20期1559-1561,共3页
China Pharmacy